Newstral
Reshma Kewalramani
- BWu Awards $4.7 Million in Funding To Develop Boston’s Life Sciences Workforcebeaconhilltimes.com
- Non-opioid proves effective for acute surgical & non-surgical painnewatlas.com
- BThe Interview: Biotech Leader and Alnylam CEO Yvonne Greenstreetbostonmagazine.com
- MFirst CRISPR gene-editing remedy authorized in U.S.mvtelegraph.com
- FDA Approves First Crispr Treatment That Might Cure Sickle CellForbes
- FDA Could Approve First Crispr Treatment Today That Might Cure Sickle CellForbes
- World-first gene therapy for inherited blood disorders approved in UKexpressandstar.com
- Raj Subramaniam wins top Asian Americans in Business Awardamericanbazaaronline.com
- BHealthcare Stocks, a Star Last Year, Are Stumbling Out of the Gate3 min readbarrons.com
- BVertex Shares Fall as Drug Fails. Analysts Say It's Time to Buy.4 minbarrons.com
- BVertex Is Buying Majority Rights to Gene-Editing Therapy From CRISPR Therapeuticsbarrons.com
- BVertex Stock Fell After a Setback on a New Drug. It’s an Opportunity for Investors.barrons.com
- Motley Fool: A promising pipeline - Sun, 13 Dec 2020 PSTThe Spokesman-Review
- Reshma Kewalramani: 'It's about raising your hand, raising your voice'bizjournals.com
- 58 executives of Indian heritage lead firms with $1 trillion revenueamericanbazaaronline.com
- '58 Indian-origin executives employ over 3.6m'The Times of India
- Four Strategies For Moving Diversity, Equity, Inclusion And Belonging Beyond Lip ServiceForbes
- MVertex Pharmaceuticals names Chief Medical Officer Reshma Kewalramani as new CEOmarketwatch.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.